Pentosan Polysulfate
PPS / Elmiron / Cartrophen
A semi-synthetic polysulfated xylanopyranose derived from beechwood hemicellulose. FDA-approved orally for interstitial cystitis (Elmiron), it is used off-label via injection for osteoarthritis and cartilage repair. Exhibits glycosaminoglycan-like properties that protect and rebuild cartilage extracellular matrix.
Half-life
20–24 hours
Typical Dose
2–3 mg/kg SC twice weekly
1.7999999999999998/3Route
subcutaneous
Category
healing
Evidence Overview
Strength of evidence across clinical, expert, and experimental lanes.
How Pentosan Polysulfate is dosed in practice
Usually taken by subcutaneous (SubQ) injection. Typical range: 2–3 mg/kg SC twice weekly. Half-life: 20–24 hours. Each card gives the dose, frequency and duration from one evidence lane: Clinical (human trials), Expert (practitioner protocols) or Experimental (early or animal data). These ranges describe what has been studied or used; they are not a prescription.
Work out the units to draw with the reconstitution calculator, how long a vial lasts with the vial duration calculator, and how levels fall between doses with the half-life calculator.
Approved only as oral Elmiron for interstitial cystitis. Injectable use in knee osteoarthritis rests on small trials (2–3 mg/kg weekly for 4–6 weeks) and a 2026 phase 2 biomarker study. Retinal damage (maculopathy) has been reported after long-term oral use and after long-term SubQ use.
- Drug label (Elmiron)
- Small trials in knee osteoarthritis
- Phase 2 biomarker trial (2026)
Practitioners use injectable PPS for osteoarthritis and post-surgical joint recovery. Anti-inflammatory and fibrinolytic properties make it a versatile healing agent. Often combined with BPC-157 and hyaluronic acid in joint protocols.
- Functional medicine practitioners — joint recovery protocols
- Veterinary orthopedic literature extrapolated to human use
- Sports medicine clinics using injectable PPS off-label
Community reports positive outcomes for chronic joint pain and cartilage regeneration. Some users combine with other healing peptides. Long-term oral use requires retinal monitoring due to maculopathy risk identified in 2018.
- Patient forums reporting improved joint mobility after 4–6 weeks
- Biohacking community protocols for cartilage regeneration
Unlock Full Evidence Sources
Get complete clinical data, expert protocols, and experimental research for Pentosan Polysulfate and 90+ other compounds with Pro.
Upgrade to ProSafety & Contraindications
- Active bleeding disorders or concurrent anticoagulant therapy
- Known hypersensitivity to pentosan polysulfate
- Pigmentary maculopathy risk with long-term oral use (retinal screening recommended)
Pentosan Polysulfate: common questions
What is Pentosan Polysulfate?
A semi-synthetic polysulfated xylanopyranose derived from beechwood hemicellulose. FDA-approved orally for interstitial cystitis (Elmiron), it is used off-label via injection for osteoarthritis and cartilage repair. Exhibits glycosaminoglycan-like properties that protect and rebuild cartilage extracellular matrix.
How is Pentosan Polysulfate dosed?
Pentosan Polysulfate is usually taken by subcutaneous (SubQ) injection. Typical range in DoseCraft's library: 2–3 mg/kg SC twice weekly. Clinical (human trials): 100 mg oral three times daily (label, interstitial cystitis); 2–3 mg/kg SubQ or IM in small knee-osteoarthritis trials; Three times daily (oral); once weekly (injectable trials); Oral reassessed at 3 months; 4–6 weeks (injectable trials). Expert (practitioner protocols): 2–3 mg/kg SC twice weekly; Twice weekly for loading, then weekly maintenance; 6–12 week cycles. Experimental (early or animal data): 2 mg/kg SC twice weekly; Twice weekly; 8–12 weeks. These ranges describe what has been studied or used; they are not a prescription.
Is Pentosan Polysulfate FDA-approved?
Pentosan Polysulfate is FDA-approved, but for a specific indication; most uses discussed for it are off-label.
What is the half-life of Pentosan Polysulfate?
DoseCraft's library lists a half-life of 20–24 hours. Half-life sets how often a compound is dosed and how long it takes to clear: about five half-lives.
Who should not use Pentosan Polysulfate?
Listed contraindications: Active bleeding disorders or concurrent anticoagulant therapy; Known hypersensitivity to pentosan polysulfate; Pigmentary maculopathy risk with long-term oral use (retinal screening recommended).
Free Guides for Pentosan Polysulfate
Information is for educational purposes only. Always consult a licensed healthcare provider before starting any peptide regimen.
Page updated . How we grade evidence: methodology.